Ceftibuten is a third-generation cephalosporin antibiotic. It is an orally-administered agent, with 2 dosage forms, capsule or oral suspension. It is marketed by Shionogi USA under the trade name Cedax
0 edits since May 19, 2008. Last edited Apr 29, 2008 by Chowbok (100).
This Compound Monograph is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Ceftibuten. See this site's terms for details.